News
Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...
Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys.
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. These drugs have transformed the treatment of type 2 diabetes by helping lower blood sugar levels and even reducing the risk of ...
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
4d
Woman's World on MSNWorried About Your Vision on Ozempic or Wegovy? Read This FirstCan Ozempic or Wegovy Make You Go Blind? What Doctors Want You To Know About the RiskSemaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and ...
Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...
People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...
5d
Medindia on MSNDiabetes Drug Semaglutide Linked to Vision Loss RiskRA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results